查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
稳定同位素标记化合物市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2029
市场调查报告书
商品编码
1359056

稳定同位素标记化合物市场 - 全球规模、份额、趋势分析、机会、预测报告，2019-2029

Stable Isotope Labeled Compounds Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，稳定同位素标记化合物的全球市场规模将达到 3.97 亿美元

由于製药和生物技术领域的研发活动活性化以及人们对治疗越来越多疾病的兴趣日益浓厚，全球稳定同位素标记化合物市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计，2022 年全球稳定同位素标记化合物市场规模为 3.035 亿美元。 BlueWeave 预测，在 2023-2029 年预测期内，全球稳定同位素标记化合物市场规模将以 3.9% 的年复合成长率增长，并于 2029 年达到 3.9671 亿美元。全球稳定同位素标记化合物市场的主要成长促进因素包括研究活动的快速成长以及製药和生物技术领域分析研究的上升趋势。癌症罹患率的增加极大地促进了使用稳定同位素标记化合物的分析研究。该市场预计将成长，主要是由于对分析活动的需求不断增加，特别是在个人化医疗和製药领域。这种融合代表着市场的强劲成长机会。 2022年，美国新发癌症病例约191万例，尤其影响生殖及消化器官系统，进一步凸显市场潜力。与蛋白质体学研究类似，稳定同位素示踪在了解营养补充食品癌症代谢的影响方面的作用有助于市场扩张。这些进步支持了市场强劲成长的预期。然而，稳定同位素标记化合物的高成本和缺乏熟练专业人员预计将限制预测期内的整体市场成长。

该报告的详细分析提供了有关全球稳定同位素标记化合物市场的成长潜力、未来趋势和统计数据的资讯。它还涵盖了推动市场总规模预测的要素。该报告致力于提供全球稳定同位素标记化合物市场的最新技术趋势和产业见解，以帮助决策者做出明智的策略决策。此外，我们也分析了市场的成长促进因素、挑战和竞争力。

目录

第1章研究框架

第2章执行摘要

第3章全球稳定同位素标记化合物市场洞察

  • 产业价值链分析
  • DROC分析
    • 成长促进因素
      • 製药和生物技术领域的研究活动增加
      • 疾病传播增加
    • 抑制因素
      • 稳定同位素标记化合物的成本高
      • 缺乏熟练的专业人员
    • 机会
      • 製药业的成长
      • 新申请
    • 任务
      • 生产复杂性
      • 竞争
  • 科技进步/最新发展
  • 法律规范
  • 波特五力分析

第4章全球稳定同位素标记化合物市场概况

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
      • 氘
      • 氧18
      • 碳13
      • 氮15
    • 按用途
      • 医学诊断
      • 工业的
      • 调查
      • 其他的
    • 按最终用户
      • 学术/研究机构
      • 医院和诊断中心
      • 製药和生物技术公司
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美稳定同位素标记化合物市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 美国
      • 加拿大

第6章欧洲稳定同位素标记化合物市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太稳定同位素标记化合物市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他国家

第8章拉丁美洲稳定同位素标记化合物市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲稳定同位素标记化合物市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争形势

  • 主要企业及其产品列表
  • 2022 年全球稳定同位素标记化合物市场份额分析
  • 透过管理参数进行竞争基准化分析
  • 主要策略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球稳定同位素标记化合物市场的影响

12：公司简介（公司简介、财务矩阵、竞争形势、关键人员、主要竞争、联络地址、策略展望、SWOT分析）

  • TAIYO NIPPON SANSO CORPORATION
  • PerkinElmer Inc.
  • Alsachim
  • Isoflex
  • Merck KGaA
  • URENCO
  • 3C Molecular
  • Trace Sciences International
  • Cambridge Isotope Laboratories, Inc.
  • IsoSciences, LLC
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • 其他主要企业

第13章关键战略建议

第14章调查方法

简介目录
Product Code: BWC23755

Global Stable Isotope Labeled Compounds Market Size Set to Touch USD 397 Million by 2029.

Global stable isotope labeled compounds market is flourishing because of an increasing research and development activities in the pharmaceutical and biotechnology sector and growing focus on treating the increasing prevalence of diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global stable isotope labeled compounds market size at USD 303.5 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global stable isotope labeled compounds market size to grow at a CAGR of 3.9% reaching a value of USD 396.71 million by 2029. Major growth drivers for the global stable isotope labeled compounds market include an increasing surge in research activities and growing trend in analytical research within the pharmaceutical and biotechnology sector. The rising incidence of cancer has notably boosted analytical investigations using stable isotope-labeled compounds. The market is set to thrive, primarily due to increasing demand for analytical activities, particularly in personalized medicine and pharmaceuticals. This convergence presents an opportunity for strong market growth. In 2022, the United States witnessed around 1.91 million new cancer cases, notably affecting the genital and digestive systems, further emphasizing the market's potential. Stable isotope tracing's role in understanding nutraceuticals' impact on cancer metabolism, as well as proteomics research, contributed to market expansion. These advances supported expectations of robust market growth. However, high cost of stable isotope labeled compounds and lack of skilled professionals are anticipated to restrain the overall market growth during the forecast period.

Global Stable Isotope Labeled Compounds Market - Overview:

Stable isotope labeling involves the utilization of non-radioactive isotopes as tracers for modeling various chemical and biochemical systems. These isotopes function as distinctive markers for compounds, detectable through techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). Commonly employed stable isotopes encompass 2H, 13C, and 15N. Researchers, particularly those engaged in metabolism-mediated toxicity studies, have shown significant interest in stable isotope-labeled compounds. Their significance has grown substantially in assessing in vivo metabolism across a wide spectrum of metabolic investigations. Beyond metabolomics research, stable isotope-labeled compounds are experiencing increasing utilization in environmental analysis, proteomics, and medical diagnostic research.

Impact of COVID-19 on Global Stable Isotope Labeled Compounds Market:

COVID-19 pandemic had a positive impact on the global stable isotope labeled compounds market. The emergence of the pandemic prompted a surge in research and development efforts worldwide as companies and institutions sought to combat the virus and devise effective management strategies. During the pandemic period, the global stable isotope labeled compounds market experienced noteworthy growth due to heightened demand for stable isotope-labeled compounds, driven by their crucial role in research related to the virus, such as investigations into the structure and dynamics of membrane proteins in pathogens like SARS-CoV-2. As the acute phase of the pandemic subsided, the market transitioned into a post-pandemic phase, and it is expected to continue its growth trajectory. The lessons learned and the increased utilization of stable isotope-labeled compounds during the pandemic are likely to contribute to healthy market expansion during the forecast period.

Global Stable Isotope Labeled Compounds Market - By End User:

On the basis of end user, the global stable isotope labeled compounds market is divided into Academic & Research Institutions, Hospital & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies segments. The pharmaceutical & biotechnology companies segment is expected to hold the highest share in the global stable isotope labeled compounds market by end user during the forecast period. These industries heavily rely on stable isotopes for drug discovery, development, and toxicity studies. Additionally, the growing focus on precision medicine and personalized therapies has intensified the demand for stable isotope-labeled compounds in these sectors. Moreover, the significant investments made by pharmaceutical giants in research and development further reinforce their prominence in utilizing stable isotopes for innovative drug-related research, ultimately contributing to their high market share.

Competitive Landscape:

Major players operating in the global stable isotope labeled compounds market include: TAIYO NIPPON SANSO CORPORATION, PerkinElmer Inc., Alsachim, Isoflex, Merck KGaA, URENCO, 3C Molecular, Trace Sciences International, Cambridge Isotope Laboratories, Inc., IsoSciences, LLC, Medical Isotopes, Inc., and Omicron Biochemicals, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Stable Isotope Labeled Compounds Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Stable Isotope Labeled Compounds Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Stable Isotope Labeled Compounds Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increase in research activities in the pharmaceutical and biotechnology sectors
      • 3.2.1.2. Growing prevalence of diseases
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of stable isotope labeled compounds
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Opportunities
      • 3.2.3.1. Pharmaceutical industry growth
      • 3.2.3.2. Emerging applications
    • 3.2.4. Challenges
      • 3.2.4.1. Production complexity
      • 3.2.4.2. Competition
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Stable Isotope Labeled Compounds Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Deuterium
      • 4.2.1.2. Oxygen-18
      • 4.2.1.3. Carbon-13
      • 4.2.1.4. Nitrogen-15
    • 4.2.2. By Application
      • 4.2.2.1. Medical Diagnostics
      • 4.2.2.2. Industrial
      • 4.2.2.3. Research
      • 4.2.2.4. Others
    • 4.2.3. By End User
      • 4.2.3.1. Academic & Research Institutions
      • 4.2.3.2. Hospital & Diagnostic Centers
      • 4.2.3.3. Pharmaceutical & Biotechnology Companies
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Stable Isotope Labeled Compounds Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Type
      • 5.2.4.1.2. By Application
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Type
      • 5.2.4.2.2. By Application
      • 5.2.4.2.3. By End User

6. Europe Stable Isotope Labeled Compounds Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By End User
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Type
      • 6.2.4.3.2. By Application
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By Type
      • 6.2.4.4.2. By Application
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Type
      • 6.2.4.5.2. By Application
      • 6.2.4.5.3. By End User
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Type
      • 6.2.4.6.2. By Application
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Type
      • 6.2.4.7.2. By Application
      • 6.2.4.7.3. By End User
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Type
      • 6.2.4.8.2. By Application
      • 6.2.4.8.3. By End User
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Type
      • 6.2.4.9.2. By Application
      • 6.2.4.9.3. By End User

7. Asia-Pacific Stable Isotope Labeled Compounds Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Type
      • 7.2.4.10.2. By Application
      • 7.2.4.10.3. By End User

8. Latin America Stable Isotope Labeled Compounds Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By End User

9. Middle East & Africa Stable Isotope Labeled Compounds Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Type
      • 9.2.4.6.2. By Application
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Type
      • 9.2.4.7.2. By Application
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Type
      • 9.2.4.8.2. By Application
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Stable Isotope Labeled Compounds Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Stable Isotope Labeled Compounds Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. TAIYO NIPPON SANSO CORPORATION
  • 12.2. PerkinElmer Inc.
  • 12.3. Alsachim
  • 12.4. Isoflex
  • 12.5. Merck KGaA
  • 12.6. URENCO
  • 12.7. 3C Molecular
  • 12.8. Trace Sciences International
  • 12.9. Cambridge Isotope Laboratories, Inc.
  • 12.10. IsoSciences, LLC
  • 12.11. Medical Isotopes, Inc.
  • 12.12. Omicron Biochemicals, Inc.
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations